GW Henssler & Associates’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-255,285
Closed -$6.44M 202
2019
Q2
$6.44M Sell
255,285
-18,453
-7% -$496K 0.58% 61
2019
Q1
$7.44M Buy
273,738
+46,132
+20% +$1.55M 0.68% 56
2018
Q4
$7.51M Buy
227,606
+3,449
+2% +$139K 0.8% 56
2018
Q3
$10.5M Buy
224,157
+8,323
+4% +$382K 0.95% 47
2018
Q2
$9.34M Buy
215,834
+17,837
+9% +$855K 0.92% 49
2018
Q1
$11M Buy
197,997
+20,979
+12% +$1.15M 1.11% 41
2017
Q4
$9.46M Buy
177,018
+44,187
+33% +$2.08M 0.88% 51
2017
Q3
$5.73M Sell
132,831
-29,188
-18% -$1.39M 0.57% 66
2017
Q2
$9.78M Buy
162,019
+9,182
+6% +$544K 1.02% 45
2017
Q1
$10.6M Buy
152,837
+17,183
+13% +$1.19M 1.14% 37
2016
Q4
$9.04M Sell
135,654
-6,558
-5% -$427K 1% 43
2016
Q3
$9.42M Sell
142,212
-1,166
-0.8% -$79.8K 1.08% 41
2016
Q2
$10.4M Buy
143,378
+6,171
+4% +$424K 1.2% 34
2016
Q1
$8.87M Buy
137,207
+9,815
+8% +$651K 1.04% 43
2015
Q4
$9.13M Sell
127,392
-1,812
-1% -$134K 1.08% 34
2015
Q3
$9.92M Buy
129,204
+11,352
+10% +$916K 1.14% 32
2015
Q2
$8.73M Buy
117,852
+81,733
+226% +$5.88M 0.95% 44
2015
Q1
$2.62M Buy
+36,119
New +$2.51M 0.3% 89

Other funds holding MD

GW Henssler & Associates's MD Position: Q3 2019 in Review

GW Henssler & Associates sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 255,285 shares — an estimated $6.44M sold.

GW Henssler & Associates first reported a position in MD in Q1 2015 and held it in 18 quarters. The position peaked at $11M in Q1 2018. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

  • GW Henssler & Associates reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
  • GW Henssler & Associates sold 255,285 Pediatrix Medical shares in Q3 2019, an estimated $6.44M.
  • GW Henssler & Associates first reported a position in Pediatrix Medical in Q1 2015 and held it in 18 quarters.
  • GW Henssler & Associates's Pediatrix Medical position peaked at $11M in Q1 2018.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on GW Henssler & Associates's 13F filing for Q3 2019, filed 18 Nov 2019.